EdgarLookup

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — All Filings

1,000 total filings on record

Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 144 3 3/A 4 4/A 424B3 424B4 424B7 425 5 5/A 8-A12B 8-K 8-K/A ARS AW CORRESP DEF 14A DEFA14A DEFM14A POS AM PREM14A PRER14A PX14A6G S-1 S-1/A S-1MEF S-3 S-3/A S-3ASR S-4 S-4/A S-8 SC 13D SC 13D/A SC 13G SC 13G/A SCHEDULE 13G SCHEDULE 13G/A SD UPLOAD
Form Description Accession Number Filed Period
4 PRIMARY DOCUMENT 0001127602-21-016102 May 10, 2021 May 7, 2021
4 PRIMARY DOCUMENT 0001127602-21-016109 May 10, 2021 May 7, 2021
4 PRIMARY DOCUMENT 0001127602-21-016111 May 10, 2021 May 7, 2021
4 PRIMARY DOCUMENT 0001127602-21-015816 May 7, 2021 May 6, 2021
4 PRIMARY DOCUMENT 0001127602-21-015655 May 6, 2021 May 4, 2021
10-Q 10-Q 0001100682-21-000010 May 4, 2021 Mar 27, 2021
S-3ASR FORM S-3ASR 0000950103-21-006693 May 4, 2021
8-K CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 8-K 0001157523-21-000575 May 4, 2021
4 PRIMARY DOCUMENT 0001127602-21-015162 May 4, 2021 May 1, 2021
4 PRIMARY DOCUMENT 0001127602-21-014394 Apr 26, 2021 Apr 22, 2021
8-K FORM 8-K 0000950103-21-005992 Apr 23, 2021 Apr 21, 2021
4 PRIMARY DOCUMENT 0001127602-21-013835 Apr 16, 2021 Apr 15, 2021
4 PRIMARY DOCUMENT 0001127602-21-013373 Apr 7, 2021 Apr 5, 2021
8-K FORM 8-K 0000950103-21-004764 Mar 29, 2021
DEF 14A DEF 14A 0001047469-21-000744 Mar 26, 2021 May 6, 2021
8-K FORM 8-K 0000950103-21-004449 Mar 23, 2021
8-K FORM 8-K 0000950103-21-003699 Mar 9, 2021 Mar 8, 2021
4 PRIMARY DOCUMENT 0001127602-21-008742 Mar 2, 2021 Mar 1, 2021
4 PRIMARY DOCUMENT 0001127602-21-008729 Mar 2, 2021 Mar 1, 2021
4 PRIMARY DOCUMENT 0001127602-21-008726 Mar 2, 2021 Feb 25, 2021
4 PRIMARY DOCUMENT 0001127602-21-008123 Feb 26, 2021 Feb 25, 2021
4 PRIMARY DOCUMENT 0001127602-21-007883 Feb 25, 2021 Feb 24, 2021
4 PRIMARY DOCUMENT 0001127602-21-007890 Feb 25, 2021 Feb 24, 2021
4 PRIMARY DOCUMENT 0001127602-21-007943 Feb 25, 2021 Feb 24, 2021
4 PRIMARY DOCUMENT 0001127602-21-007874 Feb 25, 2021 Feb 24, 2021
4 PRIMARY DOCUMENT 0001127602-21-007876 Feb 25, 2021 Feb 24, 2021
4 PRIMARY DOCUMENT 0001127602-21-007517 Feb 24, 2021 Feb 22, 2021
4 PRIMARY DOCUMENT 0001127602-21-007521 Feb 24, 2021 Feb 23, 2021
4 PRIMARY DOCUMENT 0001127602-21-007511 Feb 24, 2021 Feb 22, 2021
4 PRIMARY DOCUMENT 0001127602-21-007525 Feb 24, 2021 Feb 22, 2021
4/A PRIMARY DOCUMENT 0001127602-21-007528 Feb 24, 2021 Feb 22, 2021
4 PRIMARY DOCUMENT 0001127602-21-007536 Feb 24, 2021 Feb 4, 2021
4 PRIMARY DOCUMENT 0001127602-21-007209 Feb 23, 2021 Feb 19, 2021
4 PRIMARY DOCUMENT 0001127602-21-007205 Feb 23, 2021 Feb 19, 2021
4 PRIMARY DOCUMENT 0001127602-21-007207 Feb 23, 2021 Feb 19, 2021
8-K CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 8-K 0001157523-21-000195 Feb 17, 2021
8-K FORM 8-K 0000950103-21-002397 Feb 17, 2021
10-K 10-K 0001100682-21-000005 Feb 17, 2021 Dec 26, 2020
4 PRIMARY DOCUMENT 0001127602-21-005677 Feb 16, 2021 Feb 11, 2021
SC 13G/A SCHEDULE 13G/A 0001104659-21-017727 Feb 10, 2021
4 PRIMARY DOCUMENT 0001127602-21-003427 Feb 2, 2021 Jan 29, 2021
4 PRIMARY DOCUMENT 0001127602-21-003430 Feb 2, 2021 Jan 29, 2021
4 PRIMARY DOCUMENT 0001127602-21-003425 Feb 2, 2021 Nov 13, 2020
4 PRIMARY DOCUMENT 0001127602-21-003432 Feb 2, 2021 Feb 1, 2021
4 PRIMARY DOCUMENT 0001127602-21-003419 Feb 2, 2021
4 PRIMARY DOCUMENT 0001127602-21-003421 Feb 2, 2021 Jan 25, 2021
4 PRIMARY DOCUMENT 0001127602-21-003434 Feb 2, 2021 Dec 1, 2020
5 PRIMARY DOCUMENT 0001127602-21-003437 Feb 2, 2021 Dec 28, 2020
SC 13G/A 0000834237-21-002039 Jan 27, 2021
4 PRIMARY DOCUMENT 0001127602-21-000746 Jan 5, 2021 Jan 4, 2021